All Treatments are Provider Supervised.
Ketamine affects certain receptors and signaling pathways in the brain. Research suggests these effects may influence neuroplasticity (the brain’s ability to form and reorganize connections). Individual responses vary, and treatment is not appropriate for everyone.
Ketamine is FDA-approved as an anesthetic. Its use for mental health conditions is off-label. A consultation does not guarantee treatment, and no particular outcome can be guaranteed.
Requires clinical assessment for treatment eligibility.